Literature DB >> 1612609

Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel.

H Traupe1, A M van den Ouweland, B A van Oost, W Vogel, U Vetter, S T Warren, M Rocchi, M G Darlison, H H Ropers.   

Abstract

Human biglycan is a small proteoglycan that is expressed at high levels in the growing skeleton and in human skin at the cell surface of differentiating keratinocytes. The human gene for biglycan (BGN) has previously been mapped by in situ hybridization to the Xq27-q28 region. Employing somatic hybrid cell lines with human X chromosome breakpoints within this region, we performed a fine mapping of the gene within Xq28. Our results indicate that the biglycan gene is proximal to the red/green cone pigment genes, G6PD, and coagulation factor VIII and is distal to DXS304, DXS305, and GABRA3. The biglycan gene precisely maps to a region of the X chromosome, where, by comparative gene mapping, one would expect to find the gene for X-linked dominant chondrodysplasia punctata/ichthyosis/short stature (Happle) syndrome. Hence, BGN is a candidate gene for the Happle syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612609     DOI: 10.1016/0888-7543(92)90279-2

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Genomic characterization of human DSPG3.

Authors:  M Deere; J L Dieguez; S J Yoon; D Hewett-Emmett; A de la Chapelle; J T Hecht
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

2.  The QM gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms' tumor.

Authors:  A M van den Ouweland; M Verdijk; M M Mannens; B A van Oost
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

3.  Mutational analysis of the biglycan gene excludes it as a candidate for X-linked dominant chondrodysplasia punctata, dyskeratosis congenita, and incontinentia pigmenti.

Authors:  S Das; A Metzenberg; G S Pai; J Gitschier
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

Review 4.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

5.  Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28.

Authors:  F Kyndt; J J Schott; J N Trochu; F Baranger; O Herbert; V Scott; E Fressinaud; A David; J P Moisan; J B Bouhour; H Le Marec; B Bénichou
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 6.  Biglycan knockout mice: new models for musculoskeletal diseases.

Authors:  Marian F Young; Yanming Bi; Laurent Ameye; Xiao-Dong Chen
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

7.  Gender-specific distribution of glycosaminoglycans during cartilage mineralization of human thyroid cartilage.

Authors:  Horst Claassen; Jochen Werner
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

8.  Genetic and physical mapping of the biglycan gene on the mouse X chromosome.

Authors:  A Chatterjee; C J Faust; G E Herman
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

9.  Exclusion of the biglycan (BGN) gene as a candidate gene for the Happle syndrome, employing an intragenic single-strand conformational polymorphism.

Authors:  H Traupe; U Vetter; R Happle; L W Fisher; F P Cremers; S J Landy; R Pankau; H H Ropers
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

10.  The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene.

Authors:  C Geerkens; U Vetter; W Just; N S Fedarko; L W Fisher; M F Young; J D Termine; P G Robey; D Wöhrle; W Vogel
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.